Relationship between plasma level of cardiotrophin-1 and left ventricular mass index in patients with dilated cardiomyopathy

Journal of the American College of Cardiology

Volumn 38, Issue 5, 2001, Pages 1485-1490

  Tsutamoto, Takayoshi ^a   Wada, Atsuyuki ^a   Maeda, Keiko ^a   Mabuchi, Naoko ^a   Hayashi, Masaru ^a   Tsutsui, Takashi ^a   Ohnishi, Masato ^a   Fujii, Masanori ^a   Matsumoto, Takehiro ^a   Yamamoto, Takashi ^a   Wang, Xinwen ^a   Asai, Shigeru ^b   Tsuji, Tetsuo ^b   Tanaka, Hitoshi ^b   Saito, Yoshihiko ^c   Kuwahara, Koichiro ^c   Nakao, Kazuwa ^c   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTROPHIN 1;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CORRELATION FUNCTION; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HEART DILATATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANGIOTENSIN II; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NOREPINEPHRINE; PREDICTIVE VALUE OF TESTS; RADIOIMMUNOASSAY; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; STROKE VOLUME; VENTRICULAR REMODELING;

EID: 0035499208     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01576-5     Document Type: Article

References (32)

1. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
2. Neurohormonal interactions and adaptations in congestive heart failure
3. Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure
4. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality
5. Prognostic value of plasma intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure
6. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure
7. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
8. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
9. Basic mechanisms in congestive heart failure: Recognizing the role of proinflammatory cytokines
10. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma levels of interleukin-6 is an important prognostic predictor in patients with congestive heart failure
11. Expression cloning of cardiotrophin-1, a cytokine that induces cardiac myocyte hypertrophy
12. In vivo effects of cardiotrophin-1
13. Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro
14. Human cardiotrophin: Protein and genetic structure, biological and binding activities, and chromosomal localization
15. An immunoluminometric assay for cardiotrophin-1: A new identified cytokine is present in normal human plasma and is increased in heart failure
16. Cardiotrophin-1: Biological activities and bindings to the leukemia inhibitory factor receptor/gp130 signaling complex
17. Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development
18. cDNA cloning of rat cardiotrophin-1 (CT-1): Augmented expression of CT-1 gene in ventricle of genetically hypertensive rats
19. Augumented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rats
20. Overexpression of cardiotrophin-1 and gp130 during experimental acute Chagastic cardiomyopathy
21. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy
22. Cardiotrophin-1 (CT-1): A novel hypertrophic and cardioprotective agent
23. The heart is a source of circulating cardiotrophin-1 in humans
24. The Committee on M-mode Standardization of the American Society of echocardiography. Recommendations regarding quantitation in M-mode echocardiography: Results of a society of echocardiographic measurements
25. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
26. Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure
27. Augmented cardiotrophin-1 in experimental congestive heart failure
28. Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and regulated expression in vivo
29. Isolation and characterization of the murine cardiotrophin-1 gene: Expression and norepinephrine-induced transcriptional activation
30. Interleukin-6 family cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes
31. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice
32. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure